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after the end of the radiation treatment, which required the 
use of high dose-opioid and gabaergic pain relievers, 
chronically. In fact, this was the main factor to consider in 
our study. Local control was analized too. 
 
Results: Eight patients were treated with 3 Gy /fraction, four 
of them suffered neuropathic pain in radiation field that 
required chronic drug treatment. (RR 50%). None of the five 
patients treated with the 2 Gy per fraction technique had 
neuropathic pain in legs. 
 
Conclusion: Our preliminary results indicate that the 2 Gy 
per fraction treatment avoids the onset of neuropathic pain 
after the radiation treatment. Althoug the patient 
recruitment was low, we can afirm that both radiation 
techniques were very useful in the classic KS local control. 
The 2 Gy per fraction treatment was not associated to 
neuropathic pain, compared with the hypofractioned 
radiation treatment. 
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Purpose or Objective: To evaluate the results of stereotactic 
ablative radiotherapy (SABR) in selected metastatic sarcomas 
patients 
 
Material and Methods: Outcomes of 21 consecutive 
metastatic STS patients (32 consecutive lesions) receiving 
SABR between 2012 and 2015 at our center were 
retrospectively analyzed.  
 
Results: Most patients (85%) had a performance status of 0-1 
and the median age at treatment was 62.4 years. Metastases 
treated were localized in lung (37,5%), brain (37,5%), liver 
(9,5%), soft-tissue (12,5%) and pancreas (3%). The median 
size of the treated lesion was 2.1 cm. The median biologic 
equivalent dose delivered was 120 Gy (range, 52.7-213.8 Gy) 
delivered in a median number of 5 fractions (range, 1-13). 
The majority of patients received systemic agents prior SABR 
(16/21). With a median follow-up of 18 months, the 2 years 
local control rate was 86% (CI 95%: 51-100%; median: not 
reached), with four progressives lesions. Only one patient 
experienced a grade 3 toxicity consisting of an ear bleeding. 
Two years overall survival and progression free survival rates 
were respectively 72% (CI 95%: 47-96%) and 39% (CI 95%: 15-
63%). 
 
Conclusion: SABR in metastatic sarcoma seems to be an 
effective tool in local control that might be used as an 
alternative to other local treatments in highly selected 
patients. 
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Purpose or Objective: MRI characteristics and extent of 
disease in glioma is important for surgical planning. However, 
MRI may not adequately guide biopsy location in non-
enhancing tumors. Furthermore, post-radiation changes are 
difficult to differentiate from progressive tumor. We 
previously demonstrated the PET tracer 3,4-dihydroxy-6-
[18F]fluoro-l-phenylalanine(FDOPA) has a sensitivity for 
gliomas and may improve neurosurgical planning in adults. 
This study evaluates the utility of FDOPA-PET/CT imaging in 
biopsy and resection planning in pediatric patients. 
 
Material and Methods: MR/CT and FDOPA-PET/CT images 
were obtained in 5 patients with primary or recurrent 
malignant gliomas. Regions of interest were defined based on 
areas of MRI contrast enhancement (CE) and FDOPA uptake to 
include both concordant (MRI-CE and high-FDOPA) and 
disconcordant (MRI-non-CE and high-FDOPA, MRI-CE and low 
FDOPA) regions. Ratios of maximum tumor SUV (SUVmax) 
normalized to mean SUV (SUVmean) of normal brain tissue 
(T/N) were determined using the SUVmax from each biopsy 
coordinate and the SUVmean from contralateral normal brain 
tissue.  
 
Results: The FDOPA-PET images guided biopsy site selection 
in four patients. One patient with contrast enhancement in 
an eloquent location near a region of prior radiotherapy did 
not undergo biopsy after FDOPA-PET failed to show increased 
uptake. Average tumor SUVmax was 2.135 (range 2.92-1.27), 
and the T/N average T/N ratio was 1.6 (range 1.92-1.18). 
Biopsies within the region of highest uptake were performed 
in 3 patients and were consistent with Grade III or Grade IV, 
despite lack of contrast enhancement 1 patient. In one 
patient, SUVmax was in an eloquent region of thalamus and 
was deemed an unsafe location for biopsy. Biopsy from an 
adjacent region revealed infiltrating glioma, non-diagnostic 
for grade. Regions of increased FDOPA uptake extended 
beyond those identified with MRI in two patients.  
 
Conclusion: FDOPA-PET imaging appears to have utility in 
guiding biopsy region selection and may assist with 
identifying regions of higher-grade disease in pediatric 
patients with astrocytomas. 
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Purpose or Objective: Respiration-induced organ motion is 
one of the main contributors to intrafractional motion, 
limiting the maximum achievable accuracy in radiation 
therapy (RT). Knowledge on respiration-induced organ motion 
in children during RT is extremely scarce and urgently 
needed for better definitions of abdominal and thoracic 
safety margins. It also allows to assess whether developments 
and introduction of child-friendly breathing exercises and/or 
coaching during the treatment course could have an added 
value to control and minimize respiration-induced organ 
motion. Therefore, the aim of this study is to investigate how 
respiration influences the diaphragmatic motion, as 
indicative of organ motion in the abdomen and thorax, during 
image guided RT (IGRT) in children and to find possible 
relationships with age and height. In addition, we 
investigated trends in the respiration-induced diaphragmatic 
motion during the treatment course. 
 
Material and Methods: This retrospective study consisted of 
15 patients with a mean age of 10.6 years (range 2.2-16.9 
years) and a mean height of 140 cm (range 90–167 cm), 
treated at our institute between 2006 and 2015, for whom for 
setup correction routinely acquired evaluable images of the 
thorax were available. This amounted to a total of 15 
reference CT (refCT) scans and 86 Cone Beam CT (CBCT) 
scans. CBCTs were reconstructed for the inhale and exhale 
respiratory phases and registered to the refCT using Elekta 
XVI software. First, the vertebrae were aligned. 
Subsequently, the diaphragm was manually aligned in cranio-
caudal (CC) direction only. The result yields the mean peak-
to-peak (PP) motion (i.e., magnitude of motion) of the 
diaphragm in the CC direction, derived from registration 
outcomes of the inhale and exhale CBCTs to the refCT. 
